Neurotoxicology of Warfare Arsenical, Diphenylarsinic Acid in Humans and Experimental Models.

Cerebellar-brainstem dysfunction Clarks I and II DPAA Neurotoxicity Warfare agents behavioral function

Journal

Chemosphere
ISSN: 1879-1298
Titre abrégé: Chemosphere
Pays: England
ID NLM: 0320657

Informations de publication

Date de publication:
08 Oct 2024
Historique:
received: 08 06 2024
revised: 07 10 2024
accepted: 08 10 2024
medline: 11 10 2024
pubmed: 11 10 2024
entrez: 10 10 2024
Statut: aheadofprint

Résumé

Unused warfare chemical agents, developed in World Wars I/II dumped in the ocean or buried at various sites across the world, pose significant environmental and human health risks. This review provides description of the neurotoxicity of arsenic-based warfare chemicals known as arsenicals. We specifically described the neuropathogenesis of diphenylarsinic acid (DPAA), a chemical warfare-related organoarsenicals and a degradation product of diphenylchloroarsine (DA), diphenylcyanoarsine (DC), also known as Clark I and Clark II respectively. These arsenicals are potent emetics, which were buried at a former naval base in the town of Kamisu, Japan. Several decades after burial, their environmental decay led to contamination of underground water table. Consumption of the contaminated water by the residents manifested a neurological syndrome, which was associated with damage to the cerebellum and brainstem as well as behavioral deficits. We summarized the chronology of this damage as recorded by monitoring the exposed population over time (∼15 years). Several simulating animal studies in primates and murine models demonstrate that DPAA caused this syndrome.

Identifiants

pubmed: 39389373
pii: S0045-6535(24)02416-0
doi: 10.1016/j.chemosphere.2024.143516
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

143516

Informations de copyright

Copyright © 2024. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of Competing Interest ☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. ☐ The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:

Auteurs

Shalini Saggu (S)

UAB Centre of Excellence of Arsenicals; Department of Dermatology, School of Medicine, University of Alabama at Birmingham, Birmingham, Al, 35294.

Ritesh K Srivastava (RK)

UAB Centre of Excellence of Arsenicals; Department of Dermatology, School of Medicine, University of Alabama at Birmingham, Birmingham, Al, 35294.

Lisa McCormick (L)

School of Public Health, University of Alabama at Birmingham, Birmingham, Al, 35294.

Anupam Agarwal (A)

Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Al, 35294.

Mohammad Moshahid Khan (MM)

Department of Neurology, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA.

Mohammad Athar (M)

UAB Centre of Excellence of Arsenicals; Department of Dermatology, School of Medicine, University of Alabama at Birmingham, Birmingham, Al, 35294.

Classifications MeSH